SoylentNews is people
SoylentNews
Chemist and “semi-recreational” codemonkey Isaac Yonemoto is running a crowdfunding campaign called Project Marilyn to create open sourced, patent-free cancer drugs.
Yonemoto proposes a $75,000 stretch goal to fund an experiment he hopes will prove we can use a compound sequenced from microscopic bug cultures to treat cancer.
It’s a plan that could liberate pharmaceuticals and dramatically lower the cost of anticancer medicine. The global market for these drugs surpassed $1 trillion this year. The average monthly cost of a brand-name cancer drug in the U.S. is about $10,000, according to the IMS Institute for Healthcare Informatics.
This discussion has been archived.
No new comments can be posted.
Crowdfunding Patent-Free Cancer Drugs
|
Log In/Create an Account
| Top
| 9 comments
| Search Discussion
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
Now KEN and BARBIE are PERMANENTLY ADDICTED to MIND-ALTERING DRUGS ...
(Score: 2) by Immerman on Wednesday October 29 2014, @05:30PM
Well, if they didn't patent before publishing, then they have no legal claim to the previous work. And if they did patent, then those patents expired years ago, and they no longer have legal claim to the work. I don't see that he's trying to waive anyone else's IP rights at all - any possible rights no longer exist. As for the work not being entirely his own - I challenge you to find any example of an intellectual work that's entirely one person's. Anything, anywhere, anywhen - it's all incremental improvements built upon the work done by previous generations. Even really revolutionary stuff like jazz or Relativity was built on the shoulders of the giants who came before.
The idea that a person can climb the ladder of human knowledge, and then claim "*I* made this rung, and nobody else can step on it without my permission" is preposterous on the face of it - we only permit such claims, and only for a limited duration, in order to encourage the rung-builders to be more prolific. And the effectiveness of such incentives has long been contested: some of the greatest periods of innovation in history have been in times and places where patents did not exist.